SCHEMBL4167390

SCHEMBL4167390

NCC1CCN(c2ccc(Cl)c(Cl)c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
LMNA P02545 2/20 0.56
ALOX12 P18054 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
ADRB1 P08588 1/20 0.53
DPP4 P27487 1/20 0.50
NOTUM Q6P988 1/20 0.50
BPTF Q12830 1/20 0.47
CXCR4 P61073 1/20 0.46
THRB P10828 1/20 0.45
HTT P42858 3/20 0.44
MAPK1 P28482 1/20 0.44
DRD2 P14416 3/20 0.44
DRD4 P21917 3/20 0.44
HRH1 P35367 1/20 0.44
CCR3 P51677 1/20 0.44
KCNH2 Q12809 1/20 0.44
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4185133 0.98 MAPT (0.54) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL23901548 0.87 MAPT (0.48) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL21396910 0.86 BPTF (0.50) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL25453962 0.82 BPTF (0.41) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL12505446 0.81 HTR3E (0.48) MAPTLMNAADRB1NOTUMBPTF
SCHEMBL4169509 0.81 MAPT (0.61) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL25270202 0.81 NOTUM (0.51) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
Hydrochloric Acid SCHEMBL4170680 0.79 MAPT (0.59) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL23484656 0.77 ADRB1 (0.58) MAPTSMN1; SMN2LMNAALOX12L3MBTL1
SCHEMBL6694923 0.77 NOTUM (0.58) MAPTSMN1; SMN2LMNAALOX12L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090124663-A1 Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors NEUROSEARCH A/S (DK) 2009-05-14 US claimed
EP-1896415-A1 NOVEL N-PHENYL-PIPERIDINE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NeuroSearch A/S (DK) 2008-03-12 EP claimed
WO-2006131524-A1 NOVEL N-PHENYL-PIPERIDINE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NEUROSEARCH A/S (DK) 2006-12-14 WO claimed
US-20090124663-A1 Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors NEUROSEARCH A/S (DK) 2009-05-14 US disclosed
EP-1896415-A1 NOVEL N-PHENYL-PIPERIDINE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NeuroSearch A/S (DK) 2008-03-12 EP disclosed
WO-2006131524-A1 NOVEL N-PHENYL-PIPERIDINE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NEUROSEARCH A/S (DK) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124663-A1 Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors SLC18A2, SLC6A2, SLC18A3 MAPT 423/4885SMN1; SMN2 1786/4885LMNA 4119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.